214 related articles for article (PubMed ID: 31570051)
1. Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis.
Bae SC; Lee YH
Lupus; 2019 Oct; 28(12):1452-1459. PubMed ID: 31570051
[TBL] [Abstract][Full Text] [Related]
2. The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients.
Mousa TG; Omar HH; Emad R; Salama MI; Omar W; Fawzy M; Hassoba HM
Clin Rheumatol; 2019 Mar; 38(3):777-784. PubMed ID: 30374748
[TBL] [Abstract][Full Text] [Related]
3. Associations between the functional CD40 rs4810485 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.
Lee YH; Bae SC; Choi SJ; Ji JD; Song GG
Lupus; 2015 Oct; 24(11):1177-83. PubMed ID: 25908480
[TBL] [Abstract][Full Text] [Related]
4. Association of soluble CD40 levels with -1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus.
Tapia-Llanos R; Muñoz-Valle JF; Román-Fernández IV; Marín-Rosales M; Salazar-Camarena DC; Cruz A; Orozco-Barocio G; Guareña-Casillas JA; Oregon-Romero E; Palafox-Sánchez CA
Mol Genet Genomic Med; 2019 Dec; 7(12):e1014. PubMed ID: 31642196
[TBL] [Abstract][Full Text] [Related]
5. Association of CD40 Gene Polymorphisms With Systemic Lupus Erythematosus and Rheumatoid Arthritis in a Chinese Han Population.
Huang Q; Xu WD; Su LC; Liu XY; Huang AF
Front Immunol; 2021; 12():642929. PubMed ID: 33968033
[TBL] [Abstract][Full Text] [Related]
6. Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus.
Wu CJ; Guo J; Luo HC; Wei CD; Wang CF; Lan Y; Wei YS
Rheumatol Int; 2016 Jan; 36(1):45-52. PubMed ID: 26289938
[TBL] [Abstract][Full Text] [Related]
7. The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus.
Chen JM; Guo J; Wei CD; Wang CF; Luo HC; Wei YS; Lan Y
BMC Genet; 2015 Oct; 16():121. PubMed ID: 26474561
[TBL] [Abstract][Full Text] [Related]
8. The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis.
Lee YH; Lee HS; Choi SJ; Ji JD; Song GG
Lupus; 2012 Jan; 21(1):60-7. PubMed ID: 22004976
[TBL] [Abstract][Full Text] [Related]
9. Gene-gene interaction between CD40 and CD226 gene on systemic lupus erythematosus in the Chinese Han population.
Nie D; Li H; Yan G; Wang Z; He Z; Zhou W
Rheumatol Int; 2016 Dec; 36(12):1657-1662. PubMed ID: 27722794
[TBL] [Abstract][Full Text] [Related]
10. Associations between paraoxonase-1 and systemic lupus erythematosus.
Bae SC; Lee YH
Lupus; 2019 Nov; 28(13):1571-1576. PubMed ID: 31653192
[TBL] [Abstract][Full Text] [Related]
11. Association between interleukin-18 polymorphisms and systemic lupus erythematosus: a meta-analysis.
Song GG; Choi SJ; Ji JD; Lee YH
Mol Biol Rep; 2013 Mar; 40(3):2581-7. PubMed ID: 23238919
[TBL] [Abstract][Full Text] [Related]
12. Associations between interleukin-10 polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.
Song GG; Choi SJ; Ji JD; Lee YH
Hum Immunol; 2013 Mar; 74(3):364-70. PubMed ID: 23220432
[TBL] [Abstract][Full Text] [Related]
13. PECAM-1 gene polymorphisms and soluble PECAM-1 level in rheumatoid arthritis and systemic lupus erythematosus patients: any link with clinical atherosclerotic events?
Pamuk ON; Tozkir H; Uyanik MS; Gurkan H; Saritas F; Duymaz J; Donmez S; Yazar M; Pamuk GE
Clin Rheumatol; 2014 Dec; 33(12):1737-43. PubMed ID: 25201689
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphisms in CD40 with susceptibility to SLE in the Korean population.
Joo YB; Park BL; Shin HD; Park SY; Kim I; Bae SC
Rheumatology (Oxford); 2013 Apr; 52(4):623-30. PubMed ID: 23256180
[TBL] [Abstract][Full Text] [Related]
15. Investigation of association between CD40 current gene variants (rs4810485, rs1883832 and rs3765459) and serum CD154 protein levels in Iranian migraineurs.
Ramroodi N; Saboori H; Sanadgol N
Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):72-78. PubMed ID: 30511624
[TBL] [Abstract][Full Text] [Related]
16. The
Liu ZL; Hu J; Xiao XF; Peng Y; Zhao SP; Xiao XZ; Yang MS
Biomed Res Int; 2018; 2018():7497314. PubMed ID: 29780830
[TBL] [Abstract][Full Text] [Related]
17. Impact of CD40 gene polymorphisms on the risk of immune thrombocytopenic purpura.
AbdelGhafar MT; El-Kholy RA; Elbedewy TA; Allam AA; Eissa RAE; Samy SM; El-Khalik SRA; Rabah H
Gene; 2020 Apr; 736():144419. PubMed ID: 32018016
[TBL] [Abstract][Full Text] [Related]
18. Associations between interleukin 1 polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.
Song GG; Kim JH; Seo YH; Choi SJ; Ji JD; Lee YH
Hum Immunol; 2014 Jan; 75(1):105-12. PubMed ID: 24055697
[TBL] [Abstract][Full Text] [Related]
19. Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.
Lee YH; Song GG
Lupus; 2017 Feb; 26(2):132-138. PubMed ID: 27307447
[TBL] [Abstract][Full Text] [Related]
20. Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC
Z Rheumatol; 2017 Oct; 76(8):708-715. PubMed ID: 27447696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
